These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15982353)

  • 21. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure.
    Katz SD; Hryniewicz K; Hriljac I; Balidemaj K; Dimayuga C; Hudaihed A; Yasskiy A
    Circulation; 2005 Jan; 111(3):310-4. PubMed ID: 15655134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure.
    Gullestad L; Aukrust P; Ueland T; Espevik T; Yee G; Vagelos R; Frøland SS; Fowler M
    J Am Coll Cardiol; 1999 Dec; 34(7):2061-7. PubMed ID: 10588224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma bradykinin levels in human chronic congestive heart failure.
    Cugno M; Agostoni P; Brunner HR; Gardinali M; Agostoni A; Nussberger J
    Clin Sci (Lond); 2000 Nov; 99(5):461-6. PubMed ID: 11052927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of angiotensin-converting enzyme and phosphodiesterase type 5 improves endothelial function in heart failure.
    Hryniewicz K; Dimayuga C; Hudaihed A; Androne AS; Zheng H; Jankowski K; Katz SD
    Clin Sci (Lond); 2005 Apr; 108(4):331-8. PubMed ID: 15574127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
    Cruden NL; Fox KA; Ludlam CA; Johnston NR; Newby DE
    Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition.
    Mulder P; Compagnon P; Devaux B; Richard V; Henry JP; Elfertak L; Wimart MC; Thibout E; Comoy E; Macé B; Thuillez C
    Fundam Clin Pharmacol; 1997; 11(3):221-30. PubMed ID: 9243253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
    Ceconi C; Fox KM; Remme WJ; Simoons ML; Bertrand M; Parrinello G; Kluft C; Blann A; Cokkinos D; Ferrari R; ;
    Cardiovasc Res; 2007 Jan; 73(1):237-46. PubMed ID: 17140552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without β-blockers.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Kaetsu Y; Mizuta E; Sugihara S; Ishida K; Yanagihara K; Hisatome I; Shigemasa C
    Circ J; 2010 Nov; 74(11):2346-52. PubMed ID: 20827028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure.
    Sheth T; Parker T; Block A; Hall C; Adam A; Pfeffer MA; Stewart DJ; Qian C; Rouleau JL;
    Am J Cardiol; 2002 Sep; 90(5):496-500. PubMed ID: 12208409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure.
    Jorde UP; Vittorio T; Katz SD; Colombo PC; Latif F; Le Jemtel TH
    Circulation; 2002 Aug; 106(9):1055-7. PubMed ID: 12196328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of bradykinin on venous capacitance in health and treated chronic heart failure.
    Gunaruwan P; Maher A; Williams L; Sharman J; Schmitt M; Campbell R; Frenneaux M
    Clin Sci (Lond); 2009 Mar; 116(5):443-50. PubMed ID: 18798730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story.
    Ferrari R; Fox K
    Drugs; 2009; 69(3):265-77. PubMed ID: 19275271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients.
    Schalkwijk CG; Smulders RA; Lambert J; Donker AJ; Stehouwer CD
    Eur J Clin Invest; 2000 Oct; 30(10):853-60. PubMed ID: 11029598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inflammation and endothelial dysfunction in patients with chronic heart failure].
    Greig D; Castro P; Gabrielli L; Miranda R; Verdejo H; Alcaíno H; Bustos C; Chiong M; Godoy I; Mellado R; García L; Salas D; Vivar R; Vukasovic JL; Concepción R; Díaz-Araya G
    Rev Med Chil; 2008 Jun; 136(6):687-93. PubMed ID: 18769823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?
    Galatius S; Wroblewski H; Sørensen VB; Bie P; Parving HH; Kastrup J
    Am Heart J; 1999 Mar; 137(3):549-54. PubMed ID: 10047640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    Sharma R; Rauchhaus M; Ponikowski PP; Varney S; Poole-Wilson PA; Mann DL; Coats AJ; Anker SD
    J Am Coll Cardiol; 2000 Aug; 36(2):523-8. PubMed ID: 10933367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.